BioSpace News Archive

Computational biology is an integrated approach that employs high performance computers, state-of-the-art software and algorithms, statistical analysis, and mathematical modeling to uncover and identify the complexity of biological systems.

According to Emergen Research, the global protein engineering market size was USD 2.81 billion in 2020 and is expected to reach USD 6.95 billion in 2028 and register a revenue CAGR of 12.7% during the forecast period, 2021-2028.

The report further provides details about each segments and regions covered in the global Dental Endodontics market. The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

The pharmaceutical and healthcare sector has witnessed drastic changes in the recent years primarily due to growing prevalence of diseases, technological advancements in medicine, and increasing investments in research and development activities.

The pharmaceutical and healthcare sector has witnessed drastic changes in the recent years primarily due to growing prevalence of diseases, technological advancements in medicine, and increasing investments in research and development activities.

Nurosene Health Inc. (“Nurosene” or the “Company”) (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), is partnering, via its wholly owned subsidiary NetraMark Corp. (“NetraMark”), with Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline.

Revenue for the quarter ended December 31, 2021 was $14.6 million compared to $14.3 million for the quarter ended December 31, 2020, an increase of $0.3 million or 2.1%.

Cytokinetics, Incorporated announced that it is scheduled to report fourth quarter results on February 24, 2022 at 4:00 PM Eastern Time.

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that Arthur T. Sands, M.D., Ph.D., Nurix’s president and chief executive officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference.

GBS Inc., a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point-of-care, announced its financial results for the second quarter ended December 31, 2021 and provided a recent business update.